Jamel Ouanda - Ramsay Gnrale Deputy Projects
| GD6 Stock | EUR 11.40 0.10 0.87% |
Insider
Jamel Ouanda is Deputy Projects of Ramsay Gnrale de
| Age | 47 |
| Phone | 33 1 87 86 23 00 |
| Web | https://www.ramsaygds.fr |
Ramsay Gnrale Management Efficiency
The company has return on total asset (ROA) of 0.031 % which means that it generated a profit of $0.031 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0924 %, meaning that it generated $0.0924 on every $100 dollars invested by stockholders. Ramsay Gnrale's management efficiency ratios could be used to measure how well Ramsay Gnrale manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Karen Lynch | CVS Health Corp | 60 | |
| Lisa Stoner | Humana Inc | N/A | |
| David Falkowski | CVS Health Corp | N/A | |
| Larry McGrath | CVS Health Corp | N/A | |
| Norman Greve | CVS Health Corp | N/A | |
| Andrew VallanceOwen | Medicover AB | 72 | |
| Laurie Havanec | CVS Health Corp | 62 | |
| Timothy Wheatley | Humana Inc | 55 | |
| Staffan Ternstrom | Medicover AB | 58 | |
| Alan MD | CVS Health Corp | 61 | |
| JohnPaul Felter | Humana Inc | 40 | |
| Hanna Bjellquist | Medicover AB | N/A | |
| Jaroslaw Urbanczyk | Medicover AB | 55 | |
| Marcin Radziwill | Medicover AB | N/A | |
| Tilak Mandadi | CVS Health Corp | 59 | |
| Amy Fry | Humana Inc | N/A | |
| Shawn Guertin | CVS Health Corp | 59 | |
| Fredrik Rgmark | Medicover AB | 60 | |
| PharmD PharmD | Humana Inc | 54 | |
Management Performance
| Return On Equity | 0.0924 | |||
| Return On Asset | 0.031 |
Ramsay Gnrale de Leadership Team
Elected by the shareholders, the Ramsay Gnrale's board of directors comprises two types of representatives: Ramsay Gnrale inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ramsay. The board's role is to monitor Ramsay Gnrale's management team and ensure that shareholders' interests are well served. Ramsay Gnrale's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ramsay Gnrale's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brigitte Cachon, Brand Communication | ||
| Pierre Duperat, Director Risks | ||
| Laurence PinotLacan, Group Director | ||
| Jerome Brice, Group Officer | ||
| Georges Ichkanian, Hr Director | ||
| Jamel Ouanda, Deputy Projects | ||
| Pascal Roche, CEO Director | ||
| Isabelle Metref, Head Relations | ||
| JeanMarc Coursier, Head Department | ||
| Olivier Missoffe, Ex Consultant |
Ramsay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ramsay Gnrale a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0924 | |||
| Return On Asset | 0.031 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 5.59 B | |||
| Shares Outstanding | 110.36 M | |||
| Shares Owned By Insiders | 99.19 % | |||
| Shares Owned By Institutions | 0.10 % | |||
| Price To Earning | 47.55 X | |||
| Price To Book | 1.89 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Ramsay Stock
Ramsay Gnrale financial ratios help investors to determine whether Ramsay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ramsay with respect to the benefits of owning Ramsay Gnrale security.